Data results of just released separate coronavirus vaccine trials have raised hopes for an inoculation that could fight the virus.

A vaccine developed by British drug maker AstraZeneca, along with Oxford University, induced an immune repose in participants without any major side effects.

Meanwhile, a vaccine from Chinese company CanSinoBiologics Inc. and China’s military research unit appeared to be safe and induced an immune response in most of the volunteers who took one dose, according to Reuters.

A study was also released from German BioNTech and U.S. drug maker Pfizer on their research involving a different vaccine that uses ribonucleic acid (RNA) to help make proteins that would trigger an immune response against the virus.

However, an effective vaccine capable of protecting people and ending the pandemic remains elusive.

But that hasn’t stopped researchers from moving onto their next phases of testing.  The New York Times reports AstraZeneca is in Phase III of tests in Britain, Brazil and South Africa, with another Phase III test involving 30,000 participants in the U.S., set to begin next week.

CanSinoBiologics is also in talks with Russia, Brazil, Chile and Saudi Arabia to launch its Phase III trial for the vaccine.

According to Johns Hopkins, there are more than 14.6 million confirmed COVID-19 cases around the world, with at least 608,000 confirmed deaths.

In the U.S., talks are underway with the Trump White House and Congress on another possible COVID-19 aid package, as the president met with Republican congressional leaders on Monday.

According to the Associated Press, Senate Majority Leader Mitch McConnell has prepared $1 trillion in proposed assistance, though the Trump administration criticized some aspects of how the additional money should be spent such as virus testing.

Likewise, opposition Democrats are threatening to block the bill if McConnell’s vision falls short, with hopes to bring the Senate leader back to the negotiation table.

Leaders in the EU are on the verge of a possible stimulus plan to minimize the economic impact of COVID-19 on the bloc.

After a four-day summit, EU Council President Charles Michel said he was confident a compromise deal will be reached on a 750 billion euro ($860 billion) recovery fund.

Uber announced that it has launched a service to give public health officials access to data on drivers and riders presumed to have been in contact with someone infected with COVID-19. It will provide data on who used Uber’s services and when, while also allowing health agencies to urge affected users into quarantine.

Check out The China Report, our new weekly newsletter. Subscribe here!